How are nucleotide sequences treated in patent applications?
Source: FAQ (MPEP-Based)BlueIron Update: 2024-09-30 10 Rules5 Related FAQs This page is an FAQ based on guidance from the Manual of Patent Examining Procedure. It is provided as guidance, with links to the ground truth sources. This is information only: it is not legal advice. Nucleotide sequences that encode different proteins are typically treated as…
Read MoreWhat is a non-lengthy “Sequence Listing XML” in patent applications?
Source: FAQ (MPEP-Based)BlueIron Update: 2024-09-30 10 Rules5 Related FAQs This page is an FAQ based on guidance from the Manual of Patent Examining Procedure. It is provided as guidance, with links to the ground truth sources. This is information only: it is not legal advice. A non-lengthy “Sequence Listing XML” in patent applications refers to…
Read MoreWhat are the rules for applications filed on or after July 1, 2022, regarding sequence disclosures?
Source: FAQ (MPEP-Based)BlueIron Update: 2024-09-30 10 Rules5 Related FAQs This page is an FAQ based on guidance from the Manual of Patent Examining Procedure. It is provided as guidance, with links to the ground truth sources. This is information only: it is not legal advice. For applications filed on or after July 1, 2022, new…
Read MoreWhat MPEP sections cover Board decisions in patent applications and ex parte reexaminations?
Source: FAQ (MPEP-Based)BlueIron Update: 2024-09-30 10 Rules5 Related FAQs This page is an FAQ based on guidance from the Manual of Patent Examining Procedure. It is provided as guidance, with links to the ground truth sources. This is information only: it is not legal advice. According to MPEP § 2277, Board decisions for both patent…
Read MoreWhat is the definition of “nucleotide” according to the MPEP?
Source: FAQ (MPEP-Based)BlueIron Update: 2024-09-30 10 Rules5 Related FAQs This page is an FAQ based on guidance from the Manual of Patent Examining Procedure. It is provided as guidance, with links to the ground truth sources. This is information only: it is not legal advice. According to MPEP 2412.03(d), a “nucleotide” is defined as follows:…
Read MoreWhat types of backbone moieties are included in the MPEP’s definition of a nucleotide?
Source: FAQ (MPEP-Based)BlueIron Update: 2024-09-30 10 Rules5 Related FAQs This page is an FAQ based on guidance from the Manual of Patent Examining Procedure. It is provided as guidance, with links to the ground truth sources. This is information only: it is not legal advice. The MPEP 2412.03(d) provides a comprehensive list of backbone moieties…
Read MoreHow does the MPEP address nucleotide analogs in its definition?
Source: FAQ (MPEP-Based)BlueIron Update: 2024-09-30 10 Rules5 Related FAQs This page is an FAQ based on guidance from the Manual of Patent Examining Procedure. It is provided as guidance, with links to the ground truth sources. This is information only: it is not legal advice. The MPEP 2412.03(d) includes nucleotide analogs in its comprehensive definition…
Read MoreHow does MPEP § 2277 relate to other MPEP sections on Board decisions?
Source: FAQ (MPEP-Based)BlueIron Update: 2024-09-30 10 Rules5 Related FAQs This page is an FAQ based on guidance from the Manual of Patent Examining Procedure. It is provided as guidance, with links to the ground truth sources. This is information only: it is not legal advice. MPEP § 2277 serves as a bridge between the ex…
Read MoreAre there any more FAQs for MPEP 2159.02?
Source: FAQ (MPEP-Based)BlueIron Update: 2024-09-30 10 Rules5 Related FAQs This page is an FAQ based on guidance from the Manual of Patent Examining Procedure. It is provided as guidance, with links to the ground truth sources. This is information only: it is not legal advice. No more FAQs can be generated from MPEP 2159.02 –…
Read MoreWhat is the incorporation by reference paragraph for Sequence Listing XML?
Source: FAQ (MPEP-Based)BlueIron Update: 2024-09-29 10 Rules5 Related FAQs This page is an FAQ based on guidance from the Manual of Patent Examining Procedure. It is provided as guidance, with links to the ground truth sources. This is information only: it is not legal advice. The incorporation by reference paragraph is a crucial element when…
Read More